Blue Eagle Lithium
High Times
Home > Boards > US OTC > Medical - Healthcare >

WOUND MANAGEMENT TECHNOLOGIES, INC. (WNDM)

WNDM RSS Feed
Add WNDM Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 10/16/2018 3:43:25 PM - Followers: 18 - Board type: Free - Posts Today: 0

WOUND MANAGEMENT TECHNOLOGIES, INC. 

WNDM




Wound Management Technologies, Inc. is an emerging commercial stage company with its primary products in the $5B worldwide advanced wound care market. Wound Management's primary focus is the distribution of its unique, patented collagen product, CellerateRX®, which is FDA cleared and reimbursable under Medicare Part B. Wound Management has other advanced biotech products in development including a patented resorbable bone wax line that is in late stages of development, as well as a subsidiary focused on technology for secure healthcare communications, data collaboration and storage.


Rapid revenue growth is projected from our leading FDA cleared CellerateRX wound care products, which recent market and clinical validations show to be clinically cost effective with broad uses. CellerateRX has a competitive proprietary feature and performance advantages over other collagen-based products. It is available in powder (95% collagen) and gel (65%) forms that don't need special handling (like refrigeration). It is active in all 4 phases of wound healing. As CellerateRX revenues grow, the company is positioned to become cash flow positive and profitable in 12-18 months.



CellerateRx Activated Collagen targets a multi-billion dollar domestic and international wound care market with over 60% profit margins. A large part of the growth in the wound care markets is from diabetic ulcers.  In people with compromised health or circulation, the difference in wound healing can be significant. You can read through numerous evidence-based studies on the www.celleraterx.com website.


Wound Management Activates Orthopedic Business; Partner Chosen to Develop Products Based on its Patent; Initial License Fee Received


FORT WORTH, Texas, November 11, 2011 PRNewswire-FirstCall -

Wound Management Technologies, Inc., (OTCQB: WNDM | WNDM.PK) a leading innovator in advanced wound care solutions, today announced that its subsidiary, Resorbable Orthopedic Products, LLC, has entered into a Development and License Agreement with Newport Beach, CA-based BioStructures, LLC to develop products for bone remodeling in the human skeletal system based on ROP's patent.  BioStructures has paid ROP an initial $100K licensing fee and the agreement calls for ROP to receive additional license fees as well as royalties on sales throughout the life of the patent.  Under this contract, minimum royalties will begin in 2013 and last until 2023. Initial commercial sales from this business are expected in 2013.

"This transaction allows us to combine our portfolio of proprietary biomaterials with a patented resorbable wax carrier.  The combination of these products will further enhance the dynamic product lineup of BioStructures," said Russell Cook, CEO of BioStructures, LLC.

"We are pleased to have reached a license agreement with BioStructures to develop many of the orthopedic products related to Resorbable Orthopedic Products' patent on resorbable bone wax and bone void fillers. This agreement is the first commercial agreement for our subsidiary ROP and marks the start of a second product line for WNDM," said Deborah Hutchinson, president of Wound Management Technologies.  "We believe that BioStructures is the right partner to develop and market these important orthopedic products and we look forward to strong success of these products in the marketplace."

ROP's patent was developed by WNDM advisor Barry Constantine and his associates and was acquired by WNDM in 2009. Mr. Constantine will oversee ROP's development responsibilities with BioStructures.  "Commercialization of the BioStructures product containing the ROP technology in addition to the development and commercialization of other embodiments within the ROP patent advances the practice of orthopedic surgery," said Barry Constantine. "We are excited to see our technology move into product development with BioStructures."

Resorbable Orthopedic Products may commercialize additional products covered by the patent, including a resorbable orthopedic hemostat (resorbable bone wax), a resorbable orthopedic hemostat antimicrobial dressing and products for the veterinary market.

 


Blue Eagle Lithium
High Times
WNDM
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
WNDM News: Current Report Filing (8-k) 09/04/2018 06:09:39 AM
WNDM News: Quarterly Report (10-q) 08/13/2018 12:30:01 PM
WNDM News: Statement of Changes in Beneficial Ownership (4) 06/05/2018 07:02:27 PM
WNDM News: Quarterly Report (10-q) 05/15/2018 01:03:40 PM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#1073   I had a feeling that when I saw PithicusKong 10/16/18 03:43:25 PM
#1072   Somewhat of a reversal today.....don't know why. I PithicusKong 10/16/18 02:31:51 PM
#1071   The four hurdles of the market.....micro cap, early PithicusKong 10/16/18 09:05:54 AM
#1070   Why is the stock dropping so far??? The Tanker12 10/15/18 01:15:29 PM
#1069   Getting slaughtered today......wish I knew who was selling. PithicusKong 10/02/18 04:09:20 PM
#1068   Pullback could be early tax loss selling considering PithicusKong 10/01/18 11:30:15 AM
#1067   This has to be the most under watched Tanker12 09/27/18 09:56:40 AM
#1066   This is true..... and the person who dumped PithicusKong 09/20/18 04:16:12 PM
#1065   Me too, but that's what makes up a SPM555 09/20/18 03:15:02 PM
#1064   I think they are mistaken to sell. This Tanker12 09/20/18 03:13:32 PM
#1063   Seems like someone has been liquidating a position SPM555 09/20/18 01:57:26 PM
#1062   So far todays volume is double then normal Tanker12 09/20/18 01:03:22 PM
#1061   Someone just dumped 200K of shares. I think Tanker12 09/20/18 10:46:50 AM
#1060   I like the fact that they are thinking Tanker12 09/20/18 09:22:14 AM
#1059   not really They just spoke about how over Tanker12 09/20/18 09:20:00 AM
#1058   Thanks. Very pleasantly surprised with the trading today, SPM555 09/19/18 07:50:00 PM
#1057   I missed the first 10 minutes. Anything brooklyn137 09/19/18 07:24:36 PM
#1056   Overall I thought the call was good. It Tanker12 09/19/18 05:04:05 PM
#1055   yes it was today that was typo. They Tanker12 09/19/18 05:02:18 PM
#1054   yes it was today that was typo. They Tanker12 09/19/18 05:02:18 PM
#1053   So is the conference call today or was SPM555 09/19/18 03:45:06 PM
#1052   I e mailed IR and asked if they PithicusKong 09/19/18 02:56:14 PM
#1051   There is an email address to accept questions brooklyn137 09/19/18 02:31:52 PM
#1050   Concerning this conference call this afternoon...is there any PithicusKong 09/19/18 01:59:36 PM
#1049   Always someone willing to sell for less.....and on PithicusKong 09/19/18 10:14:23 AM
#1048   I agree this company is so far ahead Tanker12 09/18/18 08:30:18 PM
#1047   Sure is a price struggle occurring.....there are many PithicusKong 09/18/18 03:48:11 PM
#1046   Certainly discouraging to see it pulled down to PithicusKong 09/18/18 01:24:31 PM
#1045   Saw the info on Stockwatch this morning...... PithicusKong 09/17/18 01:06:35 PM
#1044   Yes, just saw it. Now if I brooklyn137 09/17/18 01:00:08 PM
#1043   Did everyone see there will be a shareholder Tanker12 09/17/18 11:13:38 AM
#1042   Hopefully whomever wanted or "needed" out is done.....did PithicusKong 09/13/18 11:31:15 AM
#1041   Someone grabbed a bargain bag of shares this PithicusKong 09/12/18 10:12:02 AM
#1040   To answer the initial question, the new partner brooklyn137 09/11/18 07:19:25 PM
#1039   And of course when individuals see this miniscule PithicusKong 09/11/18 03:41:37 PM
#1038   Today's volume is very small in relation to PithicusKong 09/11/18 02:41:10 PM
#1037   If the 50% we get is ten times Tanker12 09/11/18 02:37:52 PM
#1036   Yes...but I have not formed an opinion on PithicusKong 09/11/18 02:33:58 PM
#1035   Good question. I'm really not too familiar with Traderfan 09/11/18 02:33:48 PM
#1034   so bottom line what does this do for Tanker12 09/11/18 02:30:39 PM
#1033   I don’t understand why this stock is taking _Predator_ 09/11/18 02:25:25 PM
#1032   You guys saw this? Traderfan 09/11/18 02:15:26 PM
#1030   This is also being kept artificially low due snack 09/07/18 01:30:38 PM
#1029   Nothing wrong with the company.....it's just that interest PithicusKong 09/05/18 03:35:44 PM
#1028   Pretty fishy had a sell order in at _Predator_ 09/05/18 02:46:56 PM
#1027   This stock is starting to wear out my patience _Predator_ 09/05/18 01:56:06 PM
#1026   That would piss me right off!! _Predator_ 09/05/18 01:22:31 PM
#1025   I don't know what the deal is here.....I PithicusKong 09/05/18 12:45:52 PM
#1024   http://www.globenewswire.com/news-release/2018/08/30/1563537/0/en/Wound-Care-Mar _Predator_ 08/30/18 12:01:10 PM
#1023   I'm sure everyone has seen this press release. Tanker12 08/30/18 06:33:07 AM
PostSubject